Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 13, 2014 - Issue 6
Submit an article Journal homepage
667
Views
12
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Asenapine review, part II: clinical efficacy, safety and tolerability

Leslie CitromeClinical Professor of Psychiatry & Behavioral Sciences, New York Medical College, Valhalla, NY, USA;Address all correspondence to: 11 Medical Park Drive, Suite 106, Pomona, NY 10970, USA+1 845 362 2081; +1 845 362 8745; [email protected]
, MD MPH
Pages 803-830 | Published online: 03 May 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Haruna Matsuzaki, Masakazu Hatano, Miko Iwata & Shigeki Yamada. (2021) Treatment Continuation of Asenapine or Olanzapine in Japanese Schizophrenia Patients: A Propensity Score Matched Study. Neuropsychiatric Disease and Treatment 17, pages 3655-3661.
Read now
Donatella Marazziti, Federico Mucci, Valentina Falaschi & Liliana Dell’Osso. (2019) Asenapine for the treatment of bipolar disorder. Expert Opinion on Pharmacotherapy 20:11, pages 1321-1330.
Read now
Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Jean-Michel Azorin, Lakshmi Yatham, Sergey Mosolov, Hans-Jürgen Möller & Siegfried Kasper. (2018) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder. The World Journal of Biological Psychiatry 19:1, pages 2-58.
Read now
Suresh Durgam, Ronald P Landbloom, Mary Mackle, Xiao Wu, Maju Mathews & Henry A Nasrallah. (2017) Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study. Neuropsychiatric Disease and Treatment 13, pages 2021-2035.
Read now
Christoffer Polcwiartek, Kristian Kragholm, Ole Schjerning, Claus Graff & Jimmi Nielsen. (2016) Cardiovascular safety of antipsychotics: a clinical overview. Expert Opinion on Drug Safety 15:5, pages 679-688.
Read now
Thomas Scheidemantel, Irina Korobkova, Soham Rej & Martha Sajatovic. (2015) Asenapine for bipolar disorder. Neuropsychiatric Disease and Treatment 11, pages 3007-3017.
Read now
Ricardo P Garay, Ludovic Samalin, Ahcène Hameg & Pierre-Michel Llorca. (2015) Investigational drugs for anxiety in patients with schizophrenia. Expert Opinion on Investigational Drugs 24:4, pages 507-517.
Read now
Leslie Citrome. (2014) Asenapine review, part I: chemistry, receptor affinity profile, pharmacokinetics and metabolism. Expert Opinion on Drug Metabolism & Toxicology 10:6, pages 893-903.
Read now

Articles from other publishers (4)

Sona Aliyeva, Sakine Atila Karaca, Alper Uğur, Arın Gül Dal Poçan & Duygu Yeniceli Uğur. (2020) A novel capillary electrophoresis method for the quantification of asenapine in pharmaceuticals using Box-Behnken design. Chemical Papers 74:12, pages 4443-4451.
Crossref
Samantha Alvarez-Herrera, Raúl Escamilla, Oscar Medina-Contreras, Ricardo Saracco, Yvonne Flores, Gabriela Hurtado-Alvarado, José Luis Maldonado-García, Enrique Becerril-Villanueva, Gilberto Pérez-Sánchez & Lenin Pavón. (2020) Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics. Frontiers in Endocrinology 11.
Crossref
Paola Bozzatello, Paola Rocca, Maria Uscinska & Silvio Bellino. (2017) Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial. CNS Drugs 31:9, pages 809-819.
Crossref
John Lally & James H. MacCabe. (2015) Antipsychotic medication in schizophrenia: a review. British Medical Bulletin 114:1, pages 169-179.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.